Treatment of Legionnaires Disease

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.5, 2005-01, pp. : 605-614

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infliximab/prednisolone: Fatal Legionnaires' disease: case report

Reactions Weekly, Vol. 1, Iss. 1059, 2005-01 ,pp. : 14-15

Adis International

Access to resources Recommend Favorite

New Developments in Therapeutic Agents for Legionnaires' Disease

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 6, Iss. 4, 2007-10 ,pp. : 228-242

Bentham Science Publishers

Access to resources Recommend Favorite

Immunosuppressants/tumour necrosis factor inhibitors: Legionnaires' disease: 24 case reports

Reactions Weekly, Vol. 1, Iss. 1385, 2012-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Host pathogen interactions in Legionnaires' disease: lessons learned from a murine animal model

By Brieland J.K. Engleberg N.C. Huffnagle G.B. Remick D.G. Fantone J.C.

Immunopharmacology, Vol. 48, Iss. 3, 2000-07 ,pp. : 249-252

Elsevier

Access to resources Recommend Favorite

Treatment of Gastroesophageal Reflux Disease*

By Pettit Michael

Pharmacy World and Science, Vol. 27, Iss. 6, 2005-12 ,pp. : 432-435

Springer Publishing Company

Access to resources Recommend Favorite